South Africa Live Biotherapeutic Products And Microbiome Cdmo Market Size & Outlook

Revenue, 2023 (US$M)
$0.1
Forecast, 2030 (US$M)
$0.9
CAGR, 2024 - 2030
36.9%
Report Coverage
South Africa

South Africa live biotherapeutic products and microbiome cdmo market, 2018-2030 (US$M)

South

Related Markets

South Africa live biotherapeutic products and microbiome cdmo market highlights

  • The South Africa live biotherapeutic products and microbiome cdmo market generated a revenue of USD 0.1 million in 2023 and is expected to reach USD 0.9 million by 2030.
  • The South Africa market is expected to grow at a CAGR of 44% from 2024 to 2030.
  • In terms of segment, c.difficle was the largest revenue generating application in 2023.
  • C.difficle is the most lucrative application segment registering the fastest growth during the forecast period.


Live biotherapeutic products and microbiome cdmo market data book summary

Market revenue in 2023USD 0.1 million
Market revenue in 2030USD 0.9 million
Growth rate44% (CAGR from 2023 to 2030)
Largest segmentC.difficle
Fastest growing segmentC.difficle
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationC.difficle, Crohns disease, IBS, Diabetes
Key market players worldwideCarbios SA, Boise Cascade Co, Assembly Biosciences Inc, Wacker Chemie AG, SGS AG, Lonza Group Ltd, Arranta Bio, 4D Pharma, NIZO, Inpac Pharma


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.2% of the global live biotherapeutic products and microbiome cdmo market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa live biotherapeutic products and microbiome cdmo market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 0.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Live Biotherapeutic Products And Microbiome CDMO Market Scope

Live Biotherapeutic Products And Microbiome CDMO Market Companies

Name Profile # Employees HQ Website

South Africa live biotherapeutic products and microbiome cdmo market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to live biotherapeutic products and microbiome cdmo market will help companies and investors design strategic landscapes.


C.difficle was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the South Africa live biotherapeutic products and microbiome cdmo market based on c.difficle, crohns disease, ibs, diabetes covering the revenue growth of each sub-segment from 2018 to 2030.


South Africa is considered to be the largest market for pharmaceuticals in the sub-Saharan African region. It has one of the most developed infrastructures and the presence of a significant number of life sciences companies.

The market is expected to witness growth owing to a diverse population, the presence of well-established infrastructure, and the availability of experts. Clinical trials are outsourced to South Africa due to the easy availability of subjects for CDIs, which is the most common healthcareassociated enteric infection. Thus, growing clinical research outsourcing and increasing demand for drug development & research in the region are expected to boost market growth.

Reasons to subscribe to South Africa live biotherapeutic products and microbiome cdmo market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Africa live biotherapeutic products and microbiome cdmo market databook

  • Our clientele includes a mix of live biotherapeutic products and microbiome cdmo market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa live biotherapeutic products and microbiome cdmo market , including forecasts for subscribers. This country databook contains high-level insights into South Africa live biotherapeutic products and microbiome cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Africa live biotherapeutic products and microbiome cdmo market size, by application, 2018-2030 (US$M)

South Africa Live Biotherapeutic Products And Microbiome CDMO Market Outlook Share, 2023 & 2030 (US$M)

South Africa live biotherapeutic products and microbiome cdmo market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more